Bookmark

Add to MyYahoo RSS

AstraZeneca Group News

News on AstraZeneca Group (Ticker: AZN) continually updated from thousands of sources around the net.

Tuesday | AmericanBankingNews.com

AstraZeneca plc Receives Average Recommendation of "Hold" from Analysts

Shares of AstraZeneca plc have been given an average rating of "Hold" by the twenty-two ratings firms that are currently covering the stock, Stock Ratings News reports .

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Mon Aug 25, 2014

Seeking Alpha

Burger King And Tim Hortons: If You Can't Beat Them, Join Them

Immediate synergy in shared expertise in BKW gains breakfast expertise from THI and THI can leverage BKW for global expansion.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Restaurant Management, Mcdonalds, Yum Brands

Sat Aug 23, 2014

Seeking Alpha

Competition And Momentum Weighing On Clovis Oncology

Analysts and investors have started fretting that AstraZeneca's drug will be a stronger potential rival to Clovis's lead drug rociletinib.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry, Oncology, Diabetes, Health

Fri Aug 22, 2014

AmericanBankingNews.com

AstraZeneca plc Stock Rating Reaffirmed by Deutsche Bank

A number of other analysts have also recently weighed in on AZN. Analysts at Beaufort Securities reiterated a "hold" rating on shares of AstraZeneca plc in a research note on Friday.

Comment?

Related Topix: Biotech

AmericanBankingNews.com

Panmure Gordon Reiterates Hold Rating for AstraZeneca plc

AstraZeneca plc traded down 0.19% during mid-day trading on Friday, hitting $73.05.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

AmericanBankingNews.com

Beaufort Securities Reiterates "Hold" Rating for AstraZeneca plc

Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated a "neutral" rating on shares of AstraZeneca plc in a research note on Thursday, August 14th.

Comment?

Related Topix: Biotech

Thu Aug 21, 2014

Seeking Alpha

Nektar Therapeutics Has More To Give

Investors should know within a month whether the FDA will approve Movantik, Nektar's opioid-induced constipation drug partnered with AstraZeneca that has $1B+ potential.

Comment?

Related Topix: Startups, Nektar Therapeutics, Healthcare Law, Law, Medicine, Constipation, Health, AstraZeneca, Biotech, Healthcare Industry, Oncology

BioSpace

Pfizer Inc. Eyes Possible Actavis Bid Whilst Weighing Next Steps Over AstraZeneca PLC

Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, AstraZeneca

Hispanic Business

Astrazeneca Announces Partnership with Illumina to Develop Next...

In the first instance, intends to apply Illumina's cutting-edge technology to a novel companion diagnostic test in pivotal studies for one of its investigational oncology compounds.

Comment?

Related Topix: Scientific Instruments, Biotech, Illumina, Medicine, Healthcare Industry, Oncology, Genetics

Live Charts

London close: Astrazeneca leads FTSE higher on bid speculation

Increased speculation regarding ECB action, on the heels of weaker than forecast readings on the Eurozone economy, were offset by a weak report on UK retail sales.

Comment?

Related Topix: Biotech, Healthcare Services Group, Apparel, Financial Markets

TheStreet.com

Why AstraZeneca (AZN) Stock Is Higher Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry, Mozilla, Financial Markets

AmericanBankingNews.com

AstraZeneca plc Receives "Hold" Rating from Beaufort Securities

AstraZeneca plc opened at 4375.50 on Thursday. AstraZeneca plc has a 52 week low of GBX 3086.50 and a 52 week high of GBX 5750.00.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Customer Interaction Solutions

Illumina Announces Strategic Partnerships with AstraZeneca, Janssen...

The system will be used for clinical trials of targeted cancer therapies with a goal of developing and commercializing a multi-gene panel for therapeutic selection, resulting in a more comprehensive tool for precision medicine.

Comment?

Related Topix: Scientific Instruments, Biotech, Illumina, Medicine, Healthcare Industry, AstraZeneca, Oncology

Wed Aug 20, 2014

BioSpace

AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research

AstraZeneca and Mitsubishi Tanabe Pharma said on Wednesday they said signed a three-year research collaboration into diabetic nephropathy, or kidney failure due to diabetes.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Health, Healthcare Industry, Diabetes

Customer Interaction Solutions

Clinigen Group Further Strengthens Oncology Support Portfolio with...

Clinigen Group plc the specialty global pharmaceutical company today announces the acquisition of the global rights to the oncology support therapy, Ethyol from AstraZeneca.

Comment?

Related Topix: Oncology, Medicine, Ethyol, Amifostine (generic), Biotech, Ovarian Cancer, Health, Food and Drug Administration

Tue Aug 19, 2014

Sys-Con Media

The Zacks Analyst Blog Highlights: Tesla Motors, CarMax,...

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Comment?

Related Topix: Auto Dealers, Retail, CarMax Group, Tesla Motors, Startups, Financial Markets, OReilly Automotive, Auto Parts, AstraZeneca, Biotech, Medicine, Healthcare Industry

Forbes.com

The Negative Impact Of Pfizer's Mergers And Budget Cuts On Cancer R&D

"And then, I don't know if Mikael Dolsten is on the call, but just a question on business development, analyzing, outlicensing activity.

Comment?

Related Topix: Biotech, Healthcare Law, Law, Medicine, Health, Breast Cancer, Herceptin, Trastuzumab (generic), Oncology, Mesothelioma

TheStreet.com

How Will AstraZeneca (AZN) Stock Respond To U.S. Clearing Heart Drug Trial?

The company said the government was closing its investigation into the 18,000-patient study and no further action was planned.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry, Financial Markets, Business News

Mon Aug 18, 2014

GlobeNewswire

Us Doj Closes Investigation into Plato

UNITED STATES DEPARTMENT OF JUSTICE CLOSES INVESTIGATION INTO PLATO CLINICAL TRIAL FOR BRILINTA AstraZeneca today announced that it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial with Brilinta .

Comment?

Related Topix: US News, Biotech, Stroke, Medicine, Health, Heart Attack, Food and Drug Administration, Aspirin (generic), Bayer, Alka-Seltzer

AmericanBankingNews.com

Recent Analysts' Ratings Updates for AstraZeneca plc

A number of stock research firms have changed their ratings and price targets for AstraZeneca plc during the last seven days: AstraZeneca plc had its "underweight" rating reaffirmed by analysts at JPMorgan Chase & Co..

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry, Banking, JP Morgan Chase

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••